General Information of the Compound
Compound ID
CP0542813
Compound Name
5-(3-chlorophenyl)-4-(4-(4-methyl-1H-imidazol-5-yl)piperidin-1-yl)pyrimidine
    Show/Hide
Structure
Formula
C19H20ClN5
Molecular Weight
353.857
Canonical SMILES
Cc1nc[nH]c1C1CCN(CC1)c1ncncc1-c1cccc(Cl)c1
    Show/Hide
InChI
InChI=1S/C19H20ClN5/c1-13-18(23-12-22-13)14-5-7-25(8-6-14)19-17(10-21-11-24-19)15-3-2-4-16(20)9-15/h2-4,9-12,14H,5-8H2,1H3,(H,22,23)
    Show/Hide
InChIKey
TXEVILRPVNDVRU-UHFFFAOYSA-N
Physicochemical Property
logP
4.21252
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
57.7
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 20779094
ChEMBL ID
CHEMBL384466
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03805, Sodium/hydrogen exchanger 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000429 AP-1 Homo sapiens (Human)  1
1
IC50 = 61 nM
   TI
   LI
   LO
   TS